Stocks making the biggest moves premarket: Pfizer, Mylan, BlackRock, Domino's & more
for $2.8 billion in cash and stock. The deal will strengthen Exact Sciences' lineup of cancer testing products.
Exact Sciences also issued its quarterly numbers this morning, losing 30 cents per share compared to a consensus estimate of a 56 cent loss. The maker of the Cologuard colon cancer test also reported revenue that exceeded Street forecasts.
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
Pfizer Nears Deal to Combine off-Patent Drug Business With MylanPfizer is in talks to merge its off-patent drugs business with generic drugmaker Mylan, in a deal that would create a giant global seller of lower-priced medicines.
Leer más »
Pfizer in talks to merge off-patent drugs business with MylanPfizer Inc is in talks to merge its off-patent drugs business with Mylan NV in a...
Leer más »
Pfizer in talks to merge off-patent drugs business with Mylan: sourcePfizer Inc is in talks to merge its off-patent drugs business with Mylan NV in a...
Leer más »
Pfizer and Mylan reportedly near merger deal for low-priced drugsOne company makes Xanax and Viagra. The other makes the popular EpiPen drug for people with allergies. Now they may be close to merging.
Leer más »
Pfizer plans combination of off-patent drug business with MylanThe deal, expected to be announced Monday, will result in Pfizer shareholders owning most of the new company with Mylan's shareholders owning slightly more than 40%.
Leer más »
Asia stocks set to trade lower as US-China trade talks resumeStocks in Asia were set to trade lower on Monday as U.S.-China talks resume in Beijing later this week amid low expectations for a major breakthrough.
Leer más »